Detecting early rising Parkinson's disease (PD) symptoms could improve treatment outcomes by enabling earlier treatment ...

Detecting early rising Parkinson's disease (PD) symptoms could improve treatment outcomes by enabling earlier treatment ...

Parkinson's Disease Therapeutics Market The Parkinson's therapeutics market will grow from USD 5.92 Bn in 2024 to USD 12.83 Bn by 2033 at 8 ...

ROCKVILLE, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) (“Supernus”) today announced that it has successfully completed its previously announced acquisition of ...

A novel biodegradable gel delivers Parkinson's medications via a single weekly shot, potentially replacing current regimens of multiple pills per day. | Drug Discovery And Development ...

Detecting early rising Parkinson's disease (PD) symptoms could improve treatment outcomes by enabling earlier treatment interventions. In a new eNeuro ...

The levodopa challenge test is noninvasive, cost-effective, and easy to administer; tablets of carbidopa–levodopa are taken orally and motor symptoms are scored using the Unified Parkinson's ...

On June 25, 2025 and June 30, 2025, Supernus and Sage, respectively, filed the Premerger Notification and Report Forms required under the HSR Act with the Federal Trade Commission and the Antitrust ...

As described by the company, sepiapterin is a natural precursor of the enzymatic co-factor BH4 -- a critical co-factor for ...

AbbVie has launched its Produodopa for Parkinson’s in the EU, becoming the first and only 24-hour levodopa-based subcutaneous infusion therapy for the disease.

AbbVie also sells another long-acting therapy for advanced Parkinson's called Duodopa (levodopa–carbidopa intestinal gel) which has been bringing in around $500 million a year in sales.

Researchers from Islamic Azad University and Shahed University have found that cannabidiol (CBD) protects neuronal cells ...